In 2018, the global DNA Diagnostics/Testing market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global DNA Diagnostics/Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the DNA Diagnostics/Testing development in United States, Europe and China.

The key players covered in this study
Abbott Laboratories
Affymetrix Inc.
Agilent Technologies Inc
Applied Biosystems Group
Illumina Inc.
Cepheid Inc.
Hologic
Bio-Rad Laboratories
Dako
Alere Inc.
Roche Diagnostics
Beckman Coulter Inc.
Siemens Healthcare

Market segment by Type, the product can be split into
PCR Based Diagnostics
NGS DNA Diagnosis
In-situ Hybridization Diagnostics
Micro-arrays Based Diagnostics

Market segment by Application, split into
Oncology Diagnostics & Histopathology
Identity Diagnostics & Forensics
Pharmacogenomics Diagnostic Testing & Drug Metabolism

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global DNA Diagnostics/Testing status, future forecast, growth opportunity, key market and key players.
To present the DNA Diagnostics/Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of DNA Diagnostics/Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.